Fioricet W/ Codeine

   
Google
 
Web NewDrugInformation.com

Fioricet W/ Codeine


Drug - Fioricet W/ Codeine
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetaminophen; Butalbital; Caffeine; Codeine Phosphate
Multiple ingredients are in alphabetical order.

Strength - 325MG;50MG;40MG;30MG
The potency of the active ingredient(s), Acetaminophen; Butalbital; Caffeine; Codeine Phosphate. May repeat for multiple part products.

Applicant - WATSON PHARMS
The firm name holding legal responsibility for Fioricet W/ Codeine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020232
The FDA assigned number to Fioricet W/ Codeine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Fioricet W/ Codeine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 30, 1992
The date Fioricet W/ Codeine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Fioricet W/ Codeine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Fioricet W/ Codeine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Fioricet W/ Codeine.

Fioricet W/ Codeine